Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Jun

Showing results (51-60 of 230) with videos related to

Pageof 23
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|January 27, 2007
Potency of new structurally different oximes to reactivate cyclosarin-inhibited human brain acetylcholinesterasesKamil Kuca, Jiri Cabal, Daniel Jun, et al.
Arhiv Za Higijenu Rada I Toksikologiju|February 3, 2007
Equine butyrylcholinesterase protects rats against inhalation exposure to sublethal sarin concentrationsJiri Bajgar, Lucie Bartosova, Josef Fusek, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 13, 2007
Acetylcholinesterases--the structural similarities and differencesJirí Wiesner, Zdenek Kriz, Kamil Kuca, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 31, 2009
Why acetylcholinesterase reactivators do not work in butyrylcholinesteraseJirí Wiesner, Zdenek Kríz, Kamil Kuca, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesteraseKamil Musilek, Kamil Kuca, Daniel Jun, et al.
Chemico-Biological Interactions|June 13, 2008
A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned ratsJiri Kassa, Daniel Jun, Jana Karasova, et al.
BMJ Case Reports|January 23, 2024
Therapeutic challenges in small cell carcinoma of the larynxKimberly D'Mello, Jevan Cevik, Daniel Jun Yi Wong, et al.
Molecules (Basel, Switzerland)|September 13, 2018
Novel Group of AChE Reactivators-Synthesis, In Vitro Reactivation and Molecular Docking StudyDavid Malinak, Eugenie Nepovimova, Daniel Jun, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2005
Design and synthesis of new bis-pyridinium oxime reactivators for acetylcholinesterase inhibited by organophosphorous nerve agentsTae-Hyuk Kim, Kamil Kuca, Daniel Jun, et al.
Chemical Research in Toxicology|June 1, 2018
Vector Control and Insecticidal Resistance in the African Malaria Mosquito Anopheles gambiaeMonika Schmidt, Veronika Hrabcova, Daniel Jun, et al.
Pageof 23

Showing results (51-60 of 230) with videos related to

Sort By:
Pageof 23
Journal of Enzyme Inhibition and Medicinal Chemistry|January 27, 2007
Potency of new structurally different oximes to reactivate cyclosarin-inhibited human brain acetylcholinesterasesKamil Kuca, Jiri Cabal, Daniel Jun, et al.
Arhiv Za Higijenu Rada I Toksikologiju|February 3, 2007
Equine butyrylcholinesterase protects rats against inhalation exposure to sublethal sarin concentrationsJiri Bajgar, Lucie Bartosova, Josef Fusek, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 13, 2007
Acetylcholinesterases--the structural similarities and differencesJirí Wiesner, Zdenek Kriz, Kamil Kuca, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 31, 2009
Why acetylcholinesterase reactivators do not work in butyrylcholinesteraseJirí Wiesner, Zdenek Kríz, Kamil Kuca, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesteraseKamil Musilek, Kamil Kuca, Daniel Jun, et al.
Chemico-Biological Interactions|June 13, 2008
A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned ratsJiri Kassa, Daniel Jun, Jana Karasova, et al.
BMJ Case Reports|January 23, 2024
Therapeutic challenges in small cell carcinoma of the larynxKimberly D'Mello, Jevan Cevik, Daniel Jun Yi Wong, et al.
Molecules (Basel, Switzerland)|September 13, 2018
Novel Group of AChE Reactivators-Synthesis, In Vitro Reactivation and Molecular Docking StudyDavid Malinak, Eugenie Nepovimova, Daniel Jun, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2005
Design and synthesis of new bis-pyridinium oxime reactivators for acetylcholinesterase inhibited by organophosphorous nerve agentsTae-Hyuk Kim, Kamil Kuca, Daniel Jun, et al.
Chemical Research in Toxicology|June 1, 2018
Vector Control and Insecticidal Resistance in the African Malaria Mosquito Anopheles gambiaeMonika Schmidt, Veronika Hrabcova, Daniel Jun, et al.
Pageof 23